Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gian Life CareBOM:542918 -0.41%59 Days Payable is 1,478.14 as of Dec. 2025, which is 452% above its 10-year median of 267.99. GuruFocus rates BOM:542918 with a GF Score™ of 59/100 and a GF Value™ of ₹5.88 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Gian Life Care ranks better than 95.26% on this metric.
The historical rank and industry rank for Gian Life Care's Days Payable or its related term are showing as below:
BOM:542918'
s Days Payable Range Over the Past 10 Years
Min: 139.91 Med: 267.99 Max: 1463.79
Current: 1463.79
During the past 7 years, Gian Life Care's highest Days Payable was 1463.79. The lowest was 139.91. And the median was 267.99.
BOM:542918's Days Payable is ranked better than 95.26% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.945
vs BOM:542918: 1463.79
Gian Life Care's Days Payable
declined
from Dec. 2024 (5,630.33) to Dec. 2025 (1,478.14).
It may suggest that Gian Life Careaccelerated paying its suppliers.
The historical data trend for Gian Life Care's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542918 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Gian Life Care's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gian Life Care Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Gian Life Care's Days Payable distribution charts can be found below:
* The bar in red indicates where Gian Life Care's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Gian Life Care's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gian Life Care (BOM:542918) has a Days Payable of 1,478.14 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gian Life Care and its competitors. This is 452% above median its historical median of 267.99. Over the past decade, Gian Life Care's Days Payable has ranged from 139.91 to 1,463.79. According to the industry distribution chart, Gian Life Care ranks #9 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 4.7%.
Is Gian Life Care's Days Payable too high?
Gian Life Care's current Days Payable of 1,478.14 is 452% above median its 10-year median of 267.99. Over the past 10 years, this metric has ranged from a low of 139.91 to a high of 1,463.79. The Medical Diagnostics & Research industry median Days Payable is 64.95. Gian Life Care's value of 1,478.14 is 2176% above this industry median. Based on the distribution chart, Gian Life Care ranks #9 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Gian Life Care has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gian Life Care's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Gian Life Care ranks #9 out of 190 companies for Days Payable. This places Gian Life Care in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 64.95. Gian Life Care's value of 1,478.14 is 2176% above this benchmark. Historically, Gian Life Care's own Days Payable has ranged from 139.91 to 1,463.79 over the past decade. While the company's 10-year median is 267.99 vs. the industry median of 64.95, Gian Life Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.95, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gian Life Care's current Days Payable of 1,478.14 is 2176% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gian Life Care and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gian Life Care's current Days Payable is 1,478.14, which is 452% above median its own 10-year median of 267.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gian Life Care stock overvalued right now?
Based on GuruFocus' analysis, Gian Life Care (BOM:542918) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5.88, compared to a current price of ₹4.91 — trading 16.5% below its estimated fair value. The current Days Payable is 1,478.14, which is 452% above median its 10-year median of 267.99 and 2176% above the Medical Diagnostics & Research industry median of 64.95. Gian Life Care's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Gian Life Care (BOM:542918), the current Days Payable is 1,478.14 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gian Life Care (BOM:542918) Overvalued in 2026?
Based on GuruFocus' analysis, Gian Life Care stock appears to be undervalued.
The current stock price of ₹4.91 is trading 16.5% below its estimated GF Value™ of ₹5.88.
GuruFocus considers Gian Life Care to be Modestly Undervalued.
Key valuation signals for BOM:542918:
Days Payable: 1,478.14 (452% above median its 10-year median of 267.99)
GF Value™: ₹5.88 vs. price of ₹4.91 (16.5% below fair value)
Industry Position: 2176% above the Medical Diagnostics & Research median (#9 of 190)
No single metric tells the full story. See the BOM:542918 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The company has only one operating segment namely, Laboratories Pathological Investigations.
59GF Score
Get the complete analysis for BOM:542918
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542918 has been successfully added to your 
